Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta
- PMID: 1782214
- PMCID: PMC361843
- DOI: 10.1091/mbc.2.7.535
Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta
Abstract
Expression of transforming growth factor-beta s (TGF-beta s) 1-3 was studied in normal liver and during liver regeneration after partial hepatectomy in the rat to determine whether each of these isoforms might be involved in hepatocyte growth in vivo. Expression of the mRNAs for all three TGF-beta isoforms increases in the regenerating liver. In addition, the levels of expression of the mRNAs for several extracellular matrix proteins, including fibronectin, vitronectin, laminin, and collagen, also increase in the regenerating liver. Immunohistochemical staining analysis shows a similar distribution of all three TGF-beta s in normal and regenerating liver; however, in both tissues, the level of expression of TGF-beta 1 is 8- to 10-fold higher than that of TGF-beta 2 as determined by sandwich enzyme-linked immunosorbent assay. Expression of all three TGF-beta mRNAs is restricted to liver nonparenchymal cells. Although hepatocytes from normal and regenerating livers do not synthesize TGF-beta, they are sensitive to inhibition of growth by all three TGF-beta isoforms. Hepatocytes from regenerating livers are capable of activating latent TGF-beta 1 complexes in vitro, whereas normal hepatocytes are not. The different TGF-beta isoforms may function in an inhibitory paracrine mechanism that is activated during liver regeneration and may also regulate the synthesis of extracellular matrix components in the regenerating liver.
Similar articles
-
Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.J Cell Physiol. 1998 Sep;176(3):612-23. doi: 10.1002/(SICI)1097-4652(199809)176:3<612::AID-JCP18>3.0.CO;2-0. J Cell Physiol. 1998. PMID: 9699514
-
Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.J Clin Invest. 1995 Jul;96(1):447-55. doi: 10.1172/JCI118055. J Clin Invest. 1995. PMID: 7615817 Free PMC article.
-
Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.Hepatology. 2001 Feb;33(2):387-96. doi: 10.1053/jhep.2001.21996. Hepatology. 2001. PMID: 11172340
-
Effects of TGF-beta s in the liver: cell proliferation and fibrogenesis.Ciba Found Symp. 1991;157:165-74; discussion 174-7. doi: 10.1002/9780470514061.ch11. Ciba Found Symp. 1991. PMID: 1649033 Review.
-
Growth factors in liver development, regeneration and carcinogenesis.Prog Growth Factor Res. 1991;3(3):219-34. doi: 10.1016/0955-2235(91)90008-r. Prog Growth Factor Res. 1991. PMID: 1667366 Review.
Cited by
-
Ahnak depletion accelerates liver regeneration by modulating the TGF-β/Smad signaling pathway.BMB Rep. 2022 Aug;55(8):401-406. doi: 10.5483/BMBRep.2022.55.8.071. BMB Rep. 2022. PMID: 35880432 Free PMC article.
-
Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy.Am J Pathol. 1993 Sep;143(3):753-62. Am J Pathol. 1993. PMID: 8362974 Free PMC article.
-
TGF-β signaling in health, disease, and therapeutics.Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w. Signal Transduct Target Ther. 2024. PMID: 38514615 Free PMC article. Review.
-
The mechanism of action of transforming growth factor-beta.Gastroenterol Jpn. 1993 Mar;28 Suppl 4:81-5; discussion 86-7. doi: 10.1007/BF02782895. Gastroenterol Jpn. 1993. PMID: 8387442 Review.
-
Genetic polymorphism at codon 10 of the transforming growth factor-β1 gene in patients with alcoholic liver cirrhosis.Korean J Hepatol. 2011 Mar;17(1):37-43. doi: 10.3350/kjhep.2011.17.1.37. Korean J Hepatol. 2011. PMID: 21494076 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources